CTT Pharmaceutical Holdings, Inc. (CTTH)
| Market Cap | 2.30M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -1.67M |
| Shares Out | 57.39M |
| EPS (ttm) | -0.08 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 62,750 |
| Average Volume | 51,311 |
| Open | 0.0420 |
| Previous Close | 0.0410 |
| Day's Range | 0.0400 - 0.0420 |
| 52-Week Range | 0.0170 - 0.1518 |
| Beta | 0.92 |
| RSI | 51.58 |
| Earnings Date | n/a |
About CTTH
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company’s technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered wafer, an orally administrable wafer comprising at least one physiologically acceptable film for... [Read more]
Full Company ProfileFinancial Performance
Financial StatementsNews
CTT Pharma Grant Updates
Tampa, Florida, United States – TheNewswire – June 10, 2025 – CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) is awaiting information on our grant with Johns Hopkins University for clinical trials with...